3-143120863-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_004267.5(CHST2):c.47G>A(p.Arg16Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000871 in 1,377,120 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_004267.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151834Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000153 AC: 3AN: 19546Hom.: 0 AF XY: 0.000256 AC XY: 3AN XY: 11706
GnomAD4 exome AF: 0.0000947 AC: 116AN: 1225286Hom.: 3 Cov.: 30 AF XY: 0.000127 AC XY: 76AN XY: 599040
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151834Hom.: 0 Cov.: 33 AF XY: 0.0000405 AC XY: 3AN XY: 74154
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.47G>A (p.R16Q) alteration is located in exon 2 (coding exon 1) of the CHST2 gene. This alteration results from a G to A substitution at nucleotide position 47, causing the arginine (R) at amino acid position 16 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at